This month, researchers published 30 papers detailing results of the nine-year Encyclopedia of DNA Elements (ENCODE) project. Designed to study the 99% of the human genome that does not code for proteins, the project has so far assigned functions to around 80% of the genome. This part of the genome consists of over 70,000 promoter […]
In July, the College of American Pathologists (CAP) published accreditation standards for labs performing next-generation sequencing (NGS) for clinical applications. The standards are a new addition to the molecular pathology checklist portion of CAP’s Laboratory Accreditation Program. The checklist consists of 18 requirements divided into sections for wet bench processing and bioinformatics. Among the checklist […]
Two new programs aim to accelerate the development of antibiotics in the face of growing antibiotic-resistant infections. The NewDrugs4BadBugs project, launched in May by Europe’s Innovative Medicine Initiative (IMI), is a public-private partnership that will fund drug development and coordinate a network for drug trials. The IMI is providing €109 million ($134 million) in funding […]
A US Court of Appeals earlier this month overturned the Cross-State Air Pollution Rule, which would have established new pollution controls in 28 states and Washington, DC. The Court determined that the EPA overreached its power in requiring emissions reductions of sulfur dioxide and nitrogen oxide from Midwest power plants. The ruling stated that the […]
When it reconvenes in September, the US Congress plans to draft and approve a continuing resolution (CR) to maintain federal agencies’ budgets through the first half of fiscal 2013. Also, Congress will choose whether to alter current budgets. Adjustments cannot be made once the CR is in place. The CR could lessen the NSF’s chance […]
According to the Census of Publicly Funded Forensic Crime Laboratories, the estimated 2009 budget for publicly funded crime labs in the US grew 5.7% to $1.6 billion from the previous census in 2005. The Urban Institute collected the data in 2010 and 2011 and received responses from 97% of the 411 publicly funded US crime […]
In 2011, there were 34 partnerships between companion diagnostics makers and drug firms, up 36% from 2010. In the first quarter of 2012, 10 such partnerships were established. In July, QIAGEN’s companion diagnostic for Bristol-Myers Squibb and Eli Lilly’s colorectal cancer treatment Erbitux received FDA approval. Iressa, AstraZeneca’s drug for lung cancer introduced in 2002, […]
Half of the 450 dietary-supplement firms the FDA has inspected since 2008 have failed to adhere to 2007 regulations regarding supplement production, packing and storage. A quarter of the 1,400 firms in the $28 billion dietary-supplement industry were sent warning letters. In 2012, two-thirds of the 200 firms the FDA has inspected have violated regulations. […]
As part of an Annex to the Advanced Manufacturing Partnership Steering Committee’s June report, Capturing Domestic Competitive Advantage in Advanced Manufacturing, the results of a series of surveys of industry and university personnel about manufacturing are presented. When asked which industries were essential for US manufacturing to stay competitive, 75% of industry respondents cited advanced […]
In a report released this month, IMS predicts global drug spending to have a compound annual growth rate (CAGR) of 3%–6% through 2016 to reach $1.2 trillion. CAGRs of the US and developing countries will be 1%–4% and 12%–15%, respectively. Spending on brand name drugs, mostly by developed markets, will account for 53% of spending […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
